Skip to main content

Table 2 Patient characteristics of 109 SLND

From: Endometrial cancer—how many patients could benefit from sentinel lymph node dissection?

Age, years (range) Median 63.5 (28–89)
Grading, uterus-specimen G1 57 52%
G2 30 28%
G3 22 20%
Histopathological type
 Type I   99 91%
 Type II   10 9%
Serous   6
Clear cell   1
Carcinosarcoma   3
Uterine risk factors Low risk 53 49%
Intermediate risk 25 23%
High-intermediate risk 13 12%
High risk 18 17%
Nodal involvement Low risk 0 0%
Intermediate risk 3 12%
High-intermediate risk 7 54%
High risk 11 61%
Final FIGO stage IA 60 55%
IB 23 21%
II 5 5%
IIIC1 10 9%
IIIC2 5 5%
IIIA 1 1%
IVB 5 5%